Introduction
============

Biotin is a very important vitamin that found in some foods. It plays an important role as cofactor for pyruvate, propionyl-CoA, beta-methylcrotonyl-CoA and two isoenzymes of acetyl-CoA carboxylasein-gluconeogenesis, amino acid catabolism, and fatty acid synthesis ([@B1]).

Biotinidase deficiency is a rare and treatable inherited neurometabolic disorder ([@B2]) with an estimated incidence of 1:61, 067 population. This disorder in its severe form is much rarer with incidence of 1:137401 ([@B3]). Clinical findings of this disorder include neurological (seizure, ataxia, hypotonia, neurodevelopmental delay), dermatological (eczematous skin rash, seborrheic dermatitis), immunological, ophthalmological, respiratory problems (hyperventilation, apnea and laryngeal stridor), and alopecia ([@B1],[@B4]).

Laboratory findings include abnormal organic acids in the urine, metabolic acidosis and elevated lactate and pyruvate levels in blood. Diagnosis can be confirmed by measuring blood biotinidase activity ([@B5],[@B6]). Neuroradiological findings include encephalopathy and cerebral atrophy, cerebral edema and bilateral compensatory ventriculomegaly ([@B4]). Neurological, cutaneous and neuroimaging finding scan improve or become normal after biotin treatment in biotinidase deficiency ([@B4],[@B7]). Some of these symptoms can be

cured but some of the mremain such as hearing loss, ophthalmic defects and mental retardation ([@B8],[@B9]).

Materials &Methods
==================

Patients were diagnosed as biotinidase deficient according to clinical manifestations, developmental milestones, dermatological symptoms, seizures and neuroimaging findings. Diagnosis was confirmed in all the patients based on assessment of biotinidase activity at metabolic disorders reference laboratory in Germany. The results of biotin therapy were assessed in all the patients. The mean dosage of biotin was 5-20 mg/day.

patient's data were evaluated and categorized as age, gender, development status, general appearance, clinical manifestations, and neuroimaging findings. The data of this observational study were analyzed using descriptive method and no statistical testing was applied.

Results
=======

Sixteen patients were included in this study. They were 7 males and 9 females and the age range was from 1.5 months to 52 months. all patients were offspring of consanguineous marriage, so that in 13 patients, their parents were first cousin and in 3 other patients, their parents were second cousin. Five patients had a history of neonatal hospitalization because of respiratory distress, icter, seizure, or irritability.

13 patients had a history of seizure that most common form of seizures was tonic and myoclonic seizures (37.5%). In past medical history, one patient had a history of recurrent vomiting and another one had anorexia; two other patients had a history of recurrent respiratory and urinary infections; one of the patients had a history of loss of consciousness attacks; one had bilateral undescended testicles; and two cases had a history of severe restlessness. In physical examination, 10 patients had cutaneous involvement; 3 had erythematous lesions in pre-orifices (oral and anal), one had cradle cap (Seborrheic dermatitis) lesions, and one had erythematous, maculopapular and crusted lesions. 8 patients had alopecia and one of them had blond hair.

Weights of 3 patients were less than 5% percentile and 3 other patients had microcephaly (less than 5% percentile). Five patients had motor vision disorders (3 with strabismus and 2 with nystagmus). Hypertonicity was found in 8 patients.

Three patients had abnormal visual evoked potential (VEP) and 4 patients had abnormality in their auditory brainstem response (ABR). In lab data, 8 patients had increased levels of ammonia and lactate. Three cases had high AST and ALT. CBC, VBG (except one patient with acidosis), serum levels of calcium, phosphorus, triglyceride, and cholesterol were normal. Abdominal sonography showed hepatomegaly in one patient.

Electroencephalography (EEG) in 6 patients was abnormal and had not special pattern. In neuroimaging data, 12 patients had abnormal neuroimaging that in 9 patients, generalized brain atrophy and myelination delay were found in brain imaging, CT scan showed multiple calcification in 1 case. One patient had left hemiatrophy, two showed dismyelination in white matter, and one had abnormal signal changes in basal ganglia.

All of the cutaneous and hair symptoms were cured with biotin therapy after 3 to 6 months. Seizure in all patients was stopped (except one patient that in this patient, seizure was decreased).

In 3 patients with vision and hearing disorders, their symptoms decreased ([Table1](#T1){ref-type="table"}).

###### 

Patients and Disease Characteristics Before Biotin Therapy in Biotinidase Deficiency Cases

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Patients/Index**         **No.1**                   **No.2**              **No.3**        **No.4**        **No.5**        **No.6**              **No.7**                                    **No.8**        **No.9**           **No.10**            **No.11**                                 **No.12**             **No.13**      **No.14**            **No.15**                                **No.16**
  -------------------------- -------------------------- --------------------- --------------- --------------- --------------- --------------------- ------------------------------------------- --------------- ------------------ -------------------- ----------------------------------------- --------------------- -------------- -------------------- ---------------------------------------- ----------------------------------
  Age (Month)                3                          48                    8               5               3               3                     18                                          15              3                  4                    10                                        14                    8              4                    1.5                                      52

  Sex                        F                          F                     F               M               M               M                     M                                           F               F                  F                    M                                         M                     F              M                    F                                        F

  Neonatal hospitalization   \-                         restlessness          \-              \-              \-              restlessness          \-                                          \-              Restlessness       \-                   \-                                        \-                    \-             Seizur, icter        \-                                       Respiratory distress

  Development                Delay                      Delay                 Delay           Delay           Delay           Delay                 Delay                                       Regression      Delay              \-                   Delay                                     Regression            Delay          Delay                \-                                       Regression

  PMH                        Bad odor                   Recurrent infection   \-              \-              \-              Anorexia LOC attack   \-                                          Restlessness    Restlessness       Vomiting             Bilateral UDT                             \-                    \-             \-                   \-                                       Recurrent infection

  Skin                       Maculopapulardiaper rash   Maculopapular         Maculopapular   Maculopapular   Maculopapular   Crusted erythema      \-                                          Maculopapular   Maculopapular      \-                   \-                                        Skin lesions          \-             Erythema             \-                                       \-

  Hair                       Alopecia                   \-                    \-              Alopecia        Alopecia        \-                    \-                                          \-              Alopecia           \-                   Alopecia                                  Alopecia              Lucid          Alopecia             Alopecia                                 \-

  Organomegaly               \-                         \-                    \-              \-              \-              \-                    \-                                          \-              \-                 \-                   \-                                        \-                    \-             \-                   \-                                       \-

  Consanguineous Marriage    First\                     First\                First\          First cousin    First cousin    First cousin          First cousin                                econd cousin    First\             First cousin         econd cousin                              First cousin          First cousin   First cousin         second cousin                            First\
                             cousin                     cousin                cousin                                                                                                                            cousin                                                                                                                                                                               cousin

  Weight                     Nl                         Nl                    Nl              Nl              Nl              Nl                    dec.                                        Nl              Nl                 dec.                 dec.                                      Nl                    Nl             Nl                   Nl                                       Nl

  HC                         Nl                         dec.                  Nl              Nl              Nl              Nl                    Nl                                          Nl              dec.               Nl                   Nl                                        Nl                    Nl             dec.                 Nl                                       Nl

  Eye movement               Nl                         Strabism              Nl              Nystagmus       Nl              Nl                    Nystagmus                                   Nl              Nl                 Nl                   Nl                                        Nl                    Nl             Nystagmus            Nl                                       Strabism

  Visuality                  dec                        Nl                    Nl              Nl              Nl              Nl                    Nl                                          Nl              Nl                 Nl                   Nl                                        Nl                    Nl             Nl                   Nl                                       dec.

  Movement Disorder          \_                         \-                    \-              \-              \-              Myoclonus             \-                                          Dystonia        \-                 \-                   \-                                        \-                    \-             \-                   \-                                       \-

  Tonicity                   dec                        inc.                  dec.            inc.            inc.            inc.                  inc.                                        inc.            \-                 dec.                 inc.                                      inc.                  \-             \-                   \-                                       dec.

  DTR                        Nl                         Nl                    Nl              inc.            inc.            inc.                  inc.                                        inc.            Nl                 Nl                   inc.                                      Nl                    Nl             Nl                   Nl                                       dec.

  Seizure                    Infantile spasm            \-                    \+              \+              \+              Myoclonic             Resistant partial                           \-              \+                 Tonic-myoclonic      Tonic                                     Myoclonic             \-             \+                   Tonic                                    \+

  Lactate                    Nl                         inc.                  Nl              inc.            inc.            Nl                    inc.                                        Nl              inc.               inc.                 Nl                                        Nl                    inc.           Nl                   Nl                                       inc.

  Ammonia                    Nl                         Nl                    Nl              Nl              Nl              Nl                    Nl                                          Nl              Nl                 Nl                   Nl                                        Nl                    Nl             Nl                   Nl                                       Nl

  Pyruvate                   Nl                         Nl                    Nl              Nl              Nl              Nl                    Nl                                          Nl              Nl                 Nl                   Nl                                        Nl                    Nl             Nl                                                            Nl

  ALT                        Nl                         inc.                  Nl              Nl              Nl              inc.                  Nl                                          Nl              Nl                 Nl                   Nl                                        Nl                    Nl             Nl                   inc.                                     Nl

  AST                        Nl                         inc.                  Nl              Nl              Nl              inc.                  Nl                                          Nl              Nl                 Nl                   Nl                                        Nl                    Nl             Nl                   inc.                                     Nl

  ABR                        Disturbed                  Disturbed                                                                                                                               Nl                                                                                                Nl                    Nl             Severely disturbed   Nl                                       Disturbed

  EEG                        Moderate                   Mild                  Nl              Nl              Nl              Nl                    Nl                                          Nl              Moderate           \-                   Mild                                      Nl                    Nl             Nl                   Mild                                     Mild

  Imaging changes            yelination delay           trophy                \-              trophy          \-              \-                    Hyper-intensity in white matter on T2 MRI   \-              yelination delay   Myelinationn delay   ultiple calcification in CT, normal MRI   evere brain atrophy   trophy         rain atrophy         Left hemi-atrophy, generalized atrophy   Brain atrophy, subdural effusion

  VEP                                                   isturbed                              Nl              Nl                                    Nl                                                          isturbed           Nl                                                             Nl                    Nl             Disturbed            Nl                                       
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations: F, female; M, male; Nl, normal; dec, decrease; inc, increase; PMH, past medical history; HC, head circumference; DTR, deep tendon reflex; VEP, visual evoked potential; EEG, electroencephalography; Mild, mildly abnormal (involvement\<30%); Moderate, moderately abnormal (involvement\>30% but not all of the EEG trace)
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Discussion
==========

The results of this study demonstrated that biotin therapy in patients with biotinidase deficiency can reduce, prevent or improve neurological, dermatological and other manifestations of biotinidase deficiency. Dermatological manifestations included alopecia, loss of hair color, hypopigmentation, and eczematous and erythematous perioral and perianal papules. These findings are secondary to abnormal fatty acid synthesis because of carboxylase deficiency. Dermatological manifestations responded to administration of biotin 3 to 6 months after initiation of the treatment. The most frequent seizure types in patients with biotinidase deficiency were tonic and myoclonic. Generalized tonic seizures were seen in three patients and myoclonic seizures were seen in three cases and all of them were resolved with biotin therapy. It is important that seizures did not respond to conventional therapies, but had rapid improvement in response to biotin therapy. Cutaneous symptoms and neurodevelopmental delay were also improved after treatment with biotin.

These findings are similar to the results of studies by Wolf and Grunewald et al. that reported biotin therapy in biotinidase deficient infants with seizures (untreatable form of seizures with antiepileptic drugs), cutaneous manifestation, visual and auditory abnormalities, neuroradiological findings such as encephalopathy, and lab data such as elevated blood lactate and pyruvate concentrations is important to reduce these manifestations ([@B1],[@B10]). If biotinidase deficient patients do not treated by biotin at early stages or infancy, irreversible neurological damage, dermatological manifestations and other symptoms will progress ([@B11]).

Symptoms of biotinidase deficiency in this study are similar to previous study that contained cutaneous lesions, alopecia, neurodevelopmental delay, and brain atrophy, but in our study, there were special notices, such as all patients were the offspring of consanguineous marriage. Cutaneous lesions were not found in 6 patients and 7 patients did not have alopecia and symptoms in their hair.

MRI in half of the patients was abnormal. Cutaneous symptoms were cured with biotin therapy, and neurological symptoms such as seizure, vision and hearing impairments improved.

**In conclusion,**this study demonstrated that using biotin as an early treatment in biotinidase deficiency has a therapeutic effect in patients with this reversible neurometabolic disorder. Our study showed that all patients were the offspring of consanguineous marriage.

Cutaneous lesions were not found in 37% of patients and 43% patients did not have alopecia or any other symptoms in their hair, so absence of these symptoms do not reject the existence of biotinidase deficiency.

We thank Wagnester laboratory in Germany for conducting laboratory tests for identifying neurometabolic disorders. We thank Ms. Arezou Kermani - Jalilvand for editing the manuscript. Also, we are grateful to all parents of the patients for their cooperation and permission to publish this study.

Author contributions
====================

PK was responsible for study design and collection and interpretation of clinical data and oversaw all stages of revision and editing. NJ contributed in collection of data and wrote the first draft of this manuscript.

Other coauthor was involved in data collection and interpretation. All authors reviewed the draft of this article and agreed to submit of the final version of the manuscript.

Declaration of conflicting interests
====================================

None declared.

Funding
=======

The authors received no financial support for the research and publication of this article.

Ethical approval
================

Institutional ethical approval for the conduct of this study was obtained from the Pediatric Neurology Research Center of Shahid Beheshti University of Medical Sciences, Tehran, Iran. All parents signed a written consent for participation in the study.
